在心房扑动中使用丙吡胺引发的极度心动过速。
Extreme tachycardia complicating the use of disopyramide in atrial flutter.
作者信息
Robertson C E, Miller H C
出版信息
Br Heart J. 1980 Nov;44(5):602-3. doi: 10.1136/hrt.44.5.602.
Abstract
A 59-year-old man presented with atrial flutter and a 2:1 atrioventricular response, which, after intravenous disopyramide, became 1:1. A mechanism of slowed atrial flutter rate and improved atrioventricular nodal conduction, similar to that recognised with quinidine, is suggested.
摘要
一名59岁男性患者表现为心房扑动伴2:1房室传导，静脉注射丙吡胺后变为1:1。提示存在与奎尼丁类似的机制，即心房扑动率减慢和房室结传导改善。
相似文献
1
Extreme tachycardia complicating the use of disopyramide in atrial flutter.在心房扑动中使用丙吡胺引发的极度心动过速。
Br Heart J. 1980 Nov;44(5):602-3. doi: 10.1136/hrt.44.5.602.
2
[Conversion of chronic atrial fibrillation or flutter with disopyramide and a verapamil-quinidine combination: a comparative study ].
Dtsch Med Wochenschr. 1982 Sep 24;107(38):1419-23. doi: 10.1055/s-2008-1070140.
3
Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.丙吡胺治疗相关的室性心动过速-扑动：三例报告
Heart Lung. 1978 Sep-Oct;7(5):783-7.
4
Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.心房扑动对超速心房起搏和静脉注射磷酸丙吡胺单独及联合应用的反应。
Br Heart J. 1980 Sep;44(3):240-7. doi: 10.1136/hrt.44.3.240.
5
Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Am J Cardiol. 1978 Dec;42(6):1049-53. doi: 10.1016/0002-9149(78)90694-x.
6
The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.静脉注射磷酸丙吡胺对复发性阵发性心动过速的影响。
Br J Clin Pharmacol. 1979 Nov;8(5):441-9. doi: 10.1111/j.1365-2125.1979.tb01023.x.
7
[Paradoxic response to disopyramide and quinidine (author's transl)].对丙吡胺和奎尼丁的反常反应（作者译）
Z Kardiol. 1980 Aug;69(8):556-61.
8
Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.丙吡胺及其他类似抗心律失常药物诱发的室性快速性心律失常。
S Afr Med J. 1981 Jun 6;59(24):871-3.
9
Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.口服丙吡胺诱发的尖端扭转型室性心动过速
S Afr Med J. 1980 Sep 13;58(11):447-8.
10
Ventricular tachycardia after disopyramide.丙吡胺治疗后出现室性心动过速。
Lancet. 1978 Jan 14;1(8055):98-9. doi: 10.1016/s0140-6736(78)90038-7.
引用本文的文献
1
Pharmacological management of arrhythmias in the elderly.老年人心律失常的药物治疗
Drugs Aging. 1997 Aug;11(2):96-110. doi: 10.2165/00002512-199711020-00002.
2
Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.
Cardiovasc Drugs Ther. 1996 May;10(2):145-52. doi: 10.1007/BF00823592.
3
Intravenous cibenzoline in the management of acute supraventricular tachyarrhythmias.静脉注射西苯唑啉治疗急性室上性快速心律失常
Cardiovasc Drugs Ther. 1995 Feb;9(1):85-8. doi: 10.1007/BF00877748.
本文引用的文献
1
Electrophysiological evaluation of disopyramide in man.丙吡胺在人体中的电生理评估。
Am Heart J. 1973 Dec;86(6):771-80. doi: 10.1016/0002-8703(73)90280-9.
2
Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate.抗心律失常药物磷酸丙吡胺的电生理效应。
Am J Cardiol. 1975 Feb;35(2):282-7. doi: 10.1016/0002-9149(75)90014-4.
3
Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Am J Cardiol. 1978 Dec;42(6):1049-53. doi: 10.1016/0002-9149(78)90694-x.
Zotero 插件